Does the FDA guidance apply to all HRT types

DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

According to FDA.gov, the FDA guidance applies to all prescription hormone therapy products that contain estrogen or estrogen plus a progestogen. It does not apply to supplements or to compounded hormones from specialty pharmacies. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. This page primarily discusses commercially available hormone therapy products.

How FDA guidance applies across different HRT types

According to FDA.gov, the FDA uses one consistent safety framework for every approved hormone therapy product. This means the same rules, warnings, and labeling standards apply whether the estrogen is a pill, patch, gel, spray, ring, or vaginal insert. It also applies to progesterone or progestin products used together with estrogen when a woman has a uterus.

According to FDA-approved prescribing information, the FDA looks at the active hormone, not the brand or delivery method. If a product contains estrogen, or estrogen plus a progestogen, it falls under the FDA's guidance regarding benefits, risks, and recommended lowest-dose, shortest-use principles.

Which HRT types are included

• Oral estrogen (estradiol tablets, conjugated estrogens)
• Transdermal estrogen (patches, gels, sprays)
• Vaginal estrogen that is absorbed systemically (higher dose rings or creams)
• Combination estrogen-progestogen products (pills, patches)
• Prescription micronized progesterone or progestins used with systemic estrogen

Which HRT types are not fully covered

• Low-dose vaginal estrogen for purely local symptoms. According to FDA.gov, these are FDA approved but treated separately, because they stay mostly in the vaginal tissue and have minimal bloodstream absorption.
• Compounded hormone preparations. These are not commercially available FDA-approved products, are not required to follow FDA safety labeling, and have not been tested for consistency or long-term safety.
• Over-the-counter supplements marketed as "hormone balancers." These are not HRT and are not regulated as such.

Why this matters for you

According to FDA Drug Safety Communication, when you hear about FDA warnings or recommendations for hormone therapy, they refer specifically to FDA-approved estrogen and estrogen-progestogen products. Within that group, the FDA does not rank one form as safer than another; instead, each woman's risk depends on her health history, dose, and route. Low-dose vaginal estrogen has its own, much lighter safety profile. A qualified prescriber may help determine which option is appropriate for an individual patient.